AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a ...

AbbVie (ABBV) announced the U.S. Food and Drug Administration approval of Emblaveo (aztreonam and avibactam). This marks the first ...

The FDA has approved the intravenous antibiotic Emblaveo for adults with complicated intra-abdominal infections who have limited treatment options.

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie (ABBV) announced that the U.S. Food and Drug Administration has approved EMBLAVEO, as the first and only fixed-dose, intravenous, ...

A new study finds that sharks and rays harbor several harmful bacteria, some resistant to antibiotics, raising concerns over their impact on public health.

Most of the management guidelines for the treatment of bite infections are based on expert opinion. The goals of therapy are to prevent or treat infection, as well as minimize soft tissue damage.

Helicobacter pylori infection increases the risk for gastric carcinoma by causing chronic inflammation and decreasing the number of acid-producing glands. Gastric acid reduction by acid-suppressive ...

Expert Rev Anti Infect Ther. 2011;9(2):215-226. As with most mammalian bites, amoxicillin/clavulanic acid (augmentin) is a reasonable empiric antibiotic in an ...

The cell line was used to perform bacterial infection experiment, q-PCR assay, and invasion and migration assay for cancer cells. Lactate concentrations in supernatants of cells cultured for 24 hours ...

Background: Antimicrobial resistance represents a serious threat to human health across the globe. The cost of bringing a new antibiotic from discovery to market is high and return on investment is ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...